| abstract |
A method for preventing or treating epileptogenesis-associated diseases comprising the administration of a β-heterocyclic-β-aminoacid to a subject is disclosed. The disease can be for example head trauma, pain, stroke, anxiety, schizophrenia, psychosis, cerebral ischemia, Huntington's chorea, motor neuron disease, Alzheimer's disease, dementia of epilepsy. |